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Abstract
Background: Dengue is a major international health concern that is prevalent in tropical and sub-tropical countries. The total burden of 
febrile illnesses that presents to primary health facilities due to dengue in different parts of Karnataka is largely unknown. Objective: The 
objective was to study the different clinical manifestations, trend, and outcome of dengue cases admitted in a tertiary care hospital. Materials 
and Methods: Prospective study conducted over a period of 6 months (July-December 2013) in a tertiary care hospital at Bangalore. Dengue 
serology was done for all suspected subjects by enzyme-linked immunosorbent assay method. Detailed clinical and demographic details were 
taken at admission and serial close monitoring for signs and symptoms was done to watch for the progression of the disease. Results: Of the 100 
children admitted with probable dengue fever, 57 had confirmed dengue illness. Of these 57 cases, most of the cases were male, and 34 (60%) 
cases were in age group of 5 months to 15 years with mean age of 7.5±4.7 years. Among the serology confirmed cases, the most common 
presentation was fever in 57 (100%), followed by abdominal pain in 37 (65%), rashes in 31 (54%), myalgia in 26 (46%), and vomiting in 
23 (40%) cases. The most common hemorrhagic manifestation was cutaneous bleeding manifestations like petechiae. Of 57 cases, 46 patients 
had dengue with no warning signs, 8 had dengue fever with warning signs, and 3 had severe dengue. Conclusion: Clinical manifestations of 
dengue seem to be changing. Fever, rash, and body ache are still the common manifestations; however, clinicians in the endemic areas should 
be aware of unusual and novel presentations such as fulminant hepatic failure, splenomegaly, and myocarditis also.
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Dengue infection is a major health problem in India. Globally, the incidence of dengue has increased in the recent years. The WHO estimates that presently 
about two-fifths of the world population is at risk of this viral 
infection [1]. Dengue was first reported in 1780, when Benjamin 
Rush described this condition as “break-bone fever.” It is a 
mosquito-borne viral infection with infection four serotypes 
causing the [2]. India is one of the seven countries in the South-
East Asia region, regularly reporting the incidence of dengue 
outbreaks due to its high incidence which constantly threatens 
the health care system. The first confirmed report of dengue 
infection in India dates back to 1940s, and since then more and 
more new states have been reporting the disease, which mostly 
strikes in epidemic proportions often inflicting heavy morbidity 
and mortality [3]. The leading causes for dengue infection are 
substandard living conditions, lack of vector control and climatic 
changes [4]. Dengue infections vary in severity, from influenza-
like self-limiting illness to life-threatening dengue hemorrhagic 
fever (DHF) and dengue shock syndrome (DSS) [5].
Infection with one serotype of dengue virus (DENV) 
provides lifelong immunity to that serotype, but results only in 
partial and transient protection against subsequent infection by 
the other three serotypes. Therefore, it is possible for a person to 
be infected as many as four times, once with each serotype. It is 
well documented that sequential infection with different DENV 
serotypes increases the risk of developing dengue hemorrhagic 
fever (DHF). Ninety percent of the DHF occur in children 
<15 years of age. There is currently no specific treatment for 
DENV infection, although several potential vaccines are in 
development; therefore, the only method of preventing DENV 
transmission is vector control [6,7].
The common signs and symptoms observed are fever, 
headache, myalgia, arthralgia, and bleeding manifestations [6]. 
The exact clinical profile is important for the patient management 
and thus crucial for saving life. The Indian sub-continent has 
encountered recurrent dengue outbreaks from time to time with 
significant morbidity and mortality. Severity of the disease is 
more in children when compared to adults. This study attempts 
to delineate the salient clinical as well as laboratory findings of 
hospitalized children diagnosed as having dengue fever during 
the study period.
MATERIALS AND METHODS
This prospective observational study was conducted in 
the Department of Pediatrics of a tertiary care hospital in 
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South India (Bangalore) after obtaining Institutional Ethical 
Committee approval. This study was done for 6 months duration 
(July-December 2013). After taking informed consent from the 
parents, we included children up to 15 years of age who were 
admitted with clinical diagnosis of dengue infection, diagnostic 
criteria based on WHO guidelines [1]. Dengue was suspected 
in child who lives or traveled to an endemic area and presented 
with fever with 2 of the following criteria - nausea/vomiting/
rash/aches and pain/positive tourniquet test or leucopenia. For 
all these children, NS1, IgM and IgG antibodies to DENV 
were measured in acute and convalescent serum using enzyme-
linked immunosorbent assay (ELISA) method [8].
Clinical and demographic details of every case were 
recorded in a case record form including symptoms, signs, 
laboratory, and radiological investigations. Detailed clinical 
examination was done at the time of admission followed by 
serial monitoring to assess the progression of disease. They 
were classified as dengue with no warning signs, dengue with 
warning signs, and severe dengue. Dengue with no warning 
signs were defined as laboratory-confirmed dengue cases with 
no signs of plasma leakage. Warning signs included intense 
abdominal pain or tenderness, persistent vomiting, clinical 
fluid accumulation, mucosal bleed, lethargy, restlessness, 
liver enlargement >2 cm, an increase in hematocrit with a 
rapid decrease in platelets. Severe dengue includes signs of 
plasma leakage with rising hematocrit leading to shock/fluid 
accumulation/respiratory distress and/or severe bleeding with 
organ involvement, and impaired level of consciousness. All 
these children were monitored by twice daily measurement 
of blood pressure, appearance of new signs and symptoms in 
the form of new rash, any bleeding manifestations, edema and 
deterioration of consciousness. Blood pressure was measured 
by using an appropriate age-matched cuff in the left arm, 
with the patient in supine position, twice daily and mean of 
measurements were taken. Tourniquet test was done in those 
children who did not have obvious bleeding manifestations.
Complete blood count including differential blood count, 
packed cell volume (PCV) and absolute platelet count (APC) 
was done by using coulter analysis method. PCV and APC 
were monitored serially once a day for all subjects in the study 
group. For children having symptoms suggestive of warning 
signs, they were monitored twice daily. Liver enzymes were 
measured routinely for all children at an interval of 3 days by 
using a semi auto-analyser. The abdominal ultrasonography 
was done by an experienced sonologist in those children who 
had abdominal pain. Dengue cases were classified and managed 
according to WHO guidelines [1]. The statistical analysis was 
done by using SPSS 16.020 software.
RESULTS
A total of 100 children were admitted with clinical diagnosis of 
dengue infection. Of them 57 turned out to be positive by either 
NS1 or IgM or both. Among the 57 dengue serology positive cases, 
46 had dengue fever with no warning signs, 8 had dengue with 
warning signs, and 3 had severe dengue. The affected children 
were between 5 months and 15 years of age with the mean age of 
7.5±4.7 years. Age wise distribution of cases is given in Table 1. 
34 (59%) patients were male and 23 (41%) were female.
Fever was the clinical manifestation which was present in 
all 57 (100%) patients. Morbiliform/maculopapular rashes were 
present in 31 (54%), myalgia in 26 (46%), severe headache in 
22 (39%) and retro-orbital pain in 14 (25%) of the cases. In 
study population, abdominal pain was present in 37 (65%), 
vomiting in 23 (40%), generalized swelling in 12 (21%), and 
diarrhea in 4 (7%) patients. Totally, 31 patients had bleeding 
manifestations, of which 28 had cutaneous bleeding; 1 had 
mucosal bleeds and 2 patients had both cutaneous and mucosal 
bleed. Relative bradycardia was observed in 16 (28%) cases, 
and most of the patients with relative bradycardia were 
diagnosed to have dengue with warning signs Table 2.
Organomegaly was noted in 37 (65%) patients, out of 
which 25 had hepatomegaly, while 12 had hepatosplenomegaly. 
Ultrasonography of abdomen of all 37 patients revealed gall bladder 
wall edema. 2 patients had ascites and 3 patients had hypotension. 
Increase in hematocrit was noted in 8 patients and increase in 
aspartate aminotransferase >1000 was noted in 2 patients. Platelet 
count was <20,000 in 5 patients, 20,000-49,000 in 16 patients, 
50,000-99,000 in 30 patients, >100,000 in 6 patients, respectively. 
Elevated CK (MB) levels and reduced left ventricular function 
was noted in one patient with dengue myocarditis.
Fever was treated with paracetamol, fluid balance was 
maintained by using normal saline. 5 patients who had platelet 
count <20,000 were given 4 units of platelet transfusion each. 
Their platelet counts came to normal limits within 5 days of 
treatment. In this study, one patient with dengue fever was 
associated with acute kidney injury Grade 2, with hypertension. 
The duration of hospital stay ranged between 4 and 12 days. 
There was no mortality in the study group during the study period.
DISCUSSION
This study describes the clinical profile, laboratory features, and 
outcome of dengue infection in the pediatric population under 
Table 1: Age distribution of dengue fever in the study 
population
Age group 
(years)
Number 
of patients
Percentage
<1 2 3.52
1-5 11 19.29
6-10 23 40.35
11-15 21 36.84
Total 57 100
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15 years of age. Dengue is an important emerging disease of the 
tropical and sub-tropical regions. Since the first confirmed case 
of dengue in India, during the 1940s, intermittent reports from 
Delhi [9], Ludhiana [10], and Mangalore [11] and from other 
states have been published. The identification is by clinical 
features, but they can present with varied manifestation [9-11].
The present study describes the clinical manifestations, 
abnormalities in laboratory parameters, and outcomes of children 
admitted with dengue illness in a tertiary care hospital. Male 
children are affected more when compared to female children in 
this study, probably due to limited outdoor activity of females in 
that area. There is an increase in the number of dengue patients 
over the past few years. This is due to the rapid urbanization with 
unplanned construction activities and poor sanitation facilities 
contributing fertile breeding grounds for mosquitoes.
Increase in the alertness among medical fraternity following 
the initial epidemic and the availability of diagnostic tools 
in the hospital have contributed to the increased detection 
of cases [12]. In studies conducted from 2003 to 2006, no 
significance difference in incidence between rural and urban 
areas was noted [13]. The mean age group affected was 
7.2 years, which is in accordance with WHO data that reports 
the modal age of 6-8 years for low-endemic areas [1].
Fever was the most common clinical feature in our study 
other being abdominal pain, rashes, myalgia, vomiting, 
headache, retro-orbital pain, relative bradycardia, and edema as 
reported in previous studies [14-17]. Bleeding manifestations in 
the form of cutaneous skin bleeds were observed in majority of 
patients [18]. Skin bleeding was the most common hemorrhagic 
manifestation, which is in contrast to a previous study showing 
epistaxis as the most common form of bleeding [19]. Children 
with bleeding tendencies were not necessarily those having 
low platelet count, indicating a combination of causes such as 
thrombocytopenia, coagulopathy, and vasculopathy leading to 
bleeding manifestations [20].
One patient had evidence of myocarditis characterized with 
sinus bradycardia, increased CK-MB levels and decreased left 
ventricular functions, who improved with proper supportive 
care. Cardiac manifestations in dengue infection include 
bradycardia, which is the most common finding, although 
second degree AV block, ST elevation and rarely atrial 
fibrillation have been noted [21].
Incidence of occurrence of abdominal pain and 
hepatomegaly were not found to be significantly different 
among various groups. All the patients with abdominal pain in 
the study population showed distended gall bladder with wall 
Table 2: Clinical, laboratory features and management of dengue illness
Clinical features Number of patients with 
probable dengue (%)
Number of patients with 
dengue with warning signs (%)
Number of patients 
with severe dengue (%)
Fever 46 (100) 8 (100) 3 (100)
Rash 27 (58.7) 4 (50) -
Myalgia 20 (43.4) 6 (75) -
Retro-orbital pain 14 (30.4) - -
Headache 20 (43.4) 2 (25) -
Vomiting 15 (32.6) 8 (100) -
Abdominal pain 30 (65.2) 7 (87.5) -
Diarrhea - 4 (50) -
Edema 2 (4.3) 8 (100) 2 (66.6)
Bradycardia 5 (10.8) 8 (100) 3 (100)
Mucosal bleed - 1 (12.5) 2 (66.6)
Cutaneous bleed 21 (45.6) 7 (87.5) 2 (66.6)
Hepatomegaly 14 (30.4) 8 (100) 3 (100)
Splenomegaly 4 (8.6) 5 (62.5) 3 (100)
Ascites - - 2 (66.6)
Hypotension (<90/50 mmHg) - - 3 (100)
Thrombocytopenia 46 (100) 8 (100) 3 (100)
Rise in hematocrit - 5 (62.5) 3 (100)
Rise in AST (>1000) - - 2 (66.6)
Management Antipyretics, IV fluids 
and supportive care
Antipyretics, IV fluids, 
supportive care and platelet 
transfusion (2 patients with 
severe thrombocytopenia)
Antipyretics IV fluids 
supportive care and 
platelet transfusion
AST: Aspartate aminotransferase
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edema. Kulkarni et al. found that significantly greater number 
of children in DHF group had pain abdomen, hepatomegaly 
and bleeding tendencies, and concluded that abdominal pain 
and tender hepatomegaly may predict DHF and should be 
closely monitored for DSS [18]. Narayanan et al. found that 
hepatomegaly, positive tourniquet test, elevated haematocrit 
and thrombocytopenia were more common in DHF and DSS 
group [6]. Gupta et al. also highlighted gallbladder wall edema 
as a useful diagnostic finding that may help in prognostication 
in serology proven pediatric DHF [22]. In our study, we have 
found an increased incidence of splenomegaly among dengue 
infected cases, which were significantly higher among the 
group of dengue fever with warning signs.
In our study, all dengue diagnostic tests were done by ELISA 
method. The limitation of our study is that, the study population 
is less in number. Therefore, it is necessary to conduct these 
studies in large study population and multi-centric trial should 
be conducted.
CONCLUSION
Dengue is one of the major causes of undifferentiated fever 
presenting as a highly non-specific illness; therefore, posing 
difficulty in recognizing as a clinical entity. Clinicians in 
endemic areas thus should be aware of the clinical profile of 
dengue infection for appropriate management that can improve 
the outcome of this potentially morbid and occasionally fatal 
disease in a pediatric population.
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